Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Petroni

Showing results (81-90 of 124) with videos related to

Pageof 13
Sort By:
Journal of the American College of Surgeons|October 23, 2023
Novel Form of Breast Intraoperative Radiation Therapy with CT-Guided High-Dose-Rate Brachytherapy: Interim Results of a Prospective Phase-II Clinical TrialLena M Turkheimer, Gina R Petroni, Adam C Berger, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 2, 2011
The vaccine-site microenvironment induced by injection of incomplete Freund's adjuvant, with or without melanoma peptidesRebecca C Harris, Kimberly A Chianese-Bullock, Gina R Petroni, et al.
Cancer|July 24, 2001
Dose-escalated cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) chemotherapy for patients with diffuse lymphoma: Cancer and Leukemia Group B studies 8852 and 8854N L Bartlett, G R Petroni, B A Parker, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 8, 2005
Autoimmune toxicities associated with the administration of antitumor vaccines and low-dose interleukin-2Kimberly A Chianese-Bullock, Elizabeth M H Woodson, Huimin Tao, et al.
JAMA Network Open|November 24, 2025
Physiologic Transition During Delayed Cord Clamping With Assisted Ventilation in Preterm Infants: A Secondary Analysis of the VentFirst TrialJennifer L Fang, Karen D Fairchild, Gina R Petroni, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|June 22, 2026
Rates and predictors of intraventricular hemorrhage in the ventfirst trial with comparison to a contemporaneous cohortMarya L Strand, Dorothy I Bulas, Susan Niermeyer, et al.
Neoplasia (New York, N.Y.)|June 22, 2005
Altered expression of TFF-1 and CES-2 in Barrett's Esophagus and associated adenocarcinomasCharles A Fox, Lisa M Sapinoso, Hong Zhang, et al.
Vascular Medicine (London, England)|April 24, 2023
Alirocumab and plaque volume, calf muscle blood flow, and walking performance in peripheral artery disease: A randomized clinical trialElona Rrapo-Kaso, Adrian I Loffler, Gina R Petroni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2011
Achieving sufficient accrual to address the primary endpoint in phase III clinical trials from U.S. Cooperative Oncology GroupsAnneke T Schroen, Gina R Petroni, Hongkun Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 12, 2009
Effect of granulocyte/macrophage colony-stimulating factor on circulating CD8+ and CD4+ T-cell responses to a multipeptide melanoma vaccine: outcome of a multicenter randomized trialCraig L Slingluff, Gina R Petroni, Walter C Olson, et al.
Pageof 13

Showing results (81-90 of 124) with videos related to

Sort By:
Pageof 13
Journal of the American College of Surgeons|October 23, 2023
Novel Form of Breast Intraoperative Radiation Therapy with CT-Guided High-Dose-Rate Brachytherapy: Interim Results of a Prospective Phase-II Clinical TrialLena M Turkheimer, Gina R Petroni, Adam C Berger, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 2, 2011
The vaccine-site microenvironment induced by injection of incomplete Freund's adjuvant, with or without melanoma peptidesRebecca C Harris, Kimberly A Chianese-Bullock, Gina R Petroni, et al.
Cancer|July 24, 2001
Dose-escalated cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) chemotherapy for patients with diffuse lymphoma: Cancer and Leukemia Group B studies 8852 and 8854N L Bartlett, G R Petroni, B A Parker, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 8, 2005
Autoimmune toxicities associated with the administration of antitumor vaccines and low-dose interleukin-2Kimberly A Chianese-Bullock, Elizabeth M H Woodson, Huimin Tao, et al.
JAMA Network Open|November 24, 2025
Physiologic Transition During Delayed Cord Clamping With Assisted Ventilation in Preterm Infants: A Secondary Analysis of the VentFirst TrialJennifer L Fang, Karen D Fairchild, Gina R Petroni, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|June 22, 2026
Rates and predictors of intraventricular hemorrhage in the ventfirst trial with comparison to a contemporaneous cohortMarya L Strand, Dorothy I Bulas, Susan Niermeyer, et al.
Neoplasia (New York, N.Y.)|June 22, 2005
Altered expression of TFF-1 and CES-2 in Barrett's Esophagus and associated adenocarcinomasCharles A Fox, Lisa M Sapinoso, Hong Zhang, et al.
Vascular Medicine (London, England)|April 24, 2023
Alirocumab and plaque volume, calf muscle blood flow, and walking performance in peripheral artery disease: A randomized clinical trialElona Rrapo-Kaso, Adrian I Loffler, Gina R Petroni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2011
Achieving sufficient accrual to address the primary endpoint in phase III clinical trials from U.S. Cooperative Oncology GroupsAnneke T Schroen, Gina R Petroni, Hongkun Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 12, 2009
Effect of granulocyte/macrophage colony-stimulating factor on circulating CD8+ and CD4+ T-cell responses to a multipeptide melanoma vaccine: outcome of a multicenter randomized trialCraig L Slingluff, Gina R Petroni, Walter C Olson, et al.
Pageof 13